| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | maturation of 5.8S rRNA | 8.32e-06 | 37 | 156 | 5 | GO:0000460 | |
| GeneOntologyBiologicalProcess | DNA methylation-dependent constitutive heterochromatin formation | 1.99e-05 | 44 | 156 | 5 | GO:0006346 | |
| GeneOntologyBiologicalProcess | maturation of LSU-rRNA | 3.52e-05 | 25 | 156 | 4 | GO:0000470 | |
| GeneOntologyBiologicalProcess | response to glucagon | 3.52e-05 | 25 | 156 | 4 | GO:0033762 | |
| GeneOntologyBiologicalProcess | maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 4.13e-05 | 26 | 156 | 4 | GO:0000466 | |
| GeneOntologyBiologicalProcess | facultative heterochromatin formation | 5.95e-05 | 55 | 156 | 5 | GO:0140718 | |
| GeneOntologyCellularComponent | NoRC complex | 5.39e-05 | 2 | 154 | 2 | GO:0090536 | |
| GeneOntologyCellularComponent | condensed chromosome | TPR SMARCA5 CENPT ACTL6A NSMCE3 CHMP4B CHMP4A CTCF PES1 MTCL1 | 9.61e-05 | 307 | 154 | 10 | GO:0000793 |
| GeneOntologyCellularComponent | nuclear protein-containing complex | TPR SMARCA5 SETD1B KMT2B GPATCH1 CAMSAP3 MED14 GON4L ACTL6A POLR1G CHMP4B MXD4 CREBZF NCOR2 FZR1 GTF2E1 GTF2F1 DDX46 CHMP4A BAZ2A PES1 LAS1L NIPBL | 1.90e-04 | 1377 | 154 | 23 | GO:0140513 |
| Domain | DUF1866 | 7.20e-05 | 2 | 159 | 2 | IPR015047 | |
| Domain | DUF1866 | 7.20e-05 | 2 | 159 | 2 | PF08952 | |
| Domain | DUF1866 | 7.20e-05 | 2 | 159 | 2 | SM01165 | |
| Domain | DDT | 4.27e-04 | 4 | 159 | 2 | PF02791 | |
| Domain | DCN-prot | 7.08e-04 | 5 | 159 | 2 | IPR014764 | |
| Domain | DDT | 7.08e-04 | 5 | 159 | 2 | SM00571 | |
| Domain | Anaphylatoxin_comp_syst | 7.08e-04 | 5 | 159 | 2 | IPR018081 | |
| Domain | Anaphylatoxn_comp_syst_dom | 7.08e-04 | 5 | 159 | 2 | IPR001840 | |
| Domain | PONY_dom | 7.08e-04 | 5 | 159 | 2 | IPR005176 | |
| Domain | DCUN1 | 7.08e-04 | 5 | 159 | 2 | PS51229 | |
| Domain | Syja_N | 7.08e-04 | 5 | 159 | 2 | PF02383 | |
| Domain | DDT_dom | 7.08e-04 | 5 | 159 | 2 | IPR018501 | |
| Domain | WHIM2_dom | 7.08e-04 | 5 | 159 | 2 | IPR028941 | |
| Domain | WSD | 7.08e-04 | 5 | 159 | 2 | PF15613 | |
| Domain | SAC | 7.08e-04 | 5 | 159 | 2 | PS50275 | |
| Domain | Cullin_binding | 7.08e-04 | 5 | 159 | 2 | PF03556 | |
| Domain | SAC_dom | 7.08e-04 | 5 | 159 | 2 | IPR002013 | |
| Domain | EF-hand-dom_pair | 8.05e-04 | 287 | 159 | 9 | IPR011992 | |
| Domain | G_PATCH | 9.46e-04 | 23 | 159 | 3 | PS50174 | |
| Domain | G_patch | 9.46e-04 | 23 | 159 | 3 | SM00443 | |
| Domain | G_patch_dom | 9.46e-04 | 23 | 159 | 3 | IPR000467 | |
| Domain | G-patch | 9.46e-04 | 23 | 159 | 3 | PF01585 | |
| Domain | DDT | 1.06e-03 | 6 | 159 | 2 | PS50827 | |
| Domain | OSR1_C | 1.06e-03 | 6 | 159 | 2 | PF12202 | |
| Domain | Kinase_OSR1/WNK_CCT | 1.06e-03 | 6 | 159 | 2 | IPR024678 | |
| Domain | ANATO | 1.47e-03 | 7 | 159 | 2 | SM00104 | |
| Domain | CAMSAP_CH | 1.47e-03 | 7 | 159 | 2 | PF11971 | |
| Domain | ANAPHYLATOXIN_2 | 1.47e-03 | 7 | 159 | 2 | PS01178 | |
| Domain | ANAPHYLATOXIN_1 | 1.47e-03 | 7 | 159 | 2 | PS01177 | |
| Domain | ANATO | 1.47e-03 | 7 | 159 | 2 | PF01821 | |
| Domain | CAMSAP_CH | 1.47e-03 | 7 | 159 | 2 | IPR022613 | |
| Domain | Anaphylatoxin/fibulin | 1.47e-03 | 7 | 159 | 2 | IPR000020 | |
| Domain | AT_hook | 1.52e-03 | 27 | 159 | 3 | SM00384 | |
| Domain | AT_hook_DNA-bd_motif | 1.52e-03 | 27 | 159 | 3 | IPR017956 | |
| Domain | - | 1.81e-03 | 261 | 159 | 8 | 1.10.238.10 | |
| Domain | MacrogloblnA2_thiol-ester-bond | 1.95e-03 | 8 | 159 | 2 | IPR019565 | |
| Domain | - | 1.95e-03 | 8 | 159 | 2 | 3.30.890.10 | |
| Domain | Thiol-ester_cl | 1.95e-03 | 8 | 159 | 2 | PF10569 | |
| Domain | MacrogloblnA2_CS | 1.95e-03 | 8 | 159 | 2 | IPR019742 | |
| Domain | CH | 3.00e-03 | 70 | 159 | 4 | PF00307 | |
| Domain | IPPc | 3.10e-03 | 10 | 159 | 2 | IPR000300 | |
| Domain | A2M | 3.10e-03 | 10 | 159 | 2 | PF00207 | |
| Domain | A2M_N_2 | 3.10e-03 | 10 | 159 | 2 | IPR011625 | |
| Domain | A2M_comp | 3.10e-03 | 10 | 159 | 2 | IPR011626 | |
| Domain | A2M_recep | 3.10e-03 | 10 | 159 | 2 | PF07677 | |
| Domain | A2M_comp | 3.10e-03 | 10 | 159 | 2 | PF07678 | |
| Domain | IPPc | 3.10e-03 | 10 | 159 | 2 | SM00128 | |
| Domain | A2M_N | 3.10e-03 | 10 | 159 | 2 | PF01835 | |
| Domain | A2M_N | 3.10e-03 | 10 | 159 | 2 | IPR002890 | |
| Domain | A-macroglobulin_rcpt-bd | 3.10e-03 | 10 | 159 | 2 | IPR009048 | |
| Domain | ALPHA_2_MACROGLOBULIN | 3.10e-03 | 10 | 159 | 2 | PS00477 | |
| Domain | A2M_N_2 | 3.10e-03 | 10 | 159 | 2 | PF07703 | |
| Domain | Macroglobln_a2 | 3.10e-03 | 10 | 159 | 2 | IPR001599 | |
| Domain | CH | 3.49e-03 | 73 | 159 | 4 | PS50021 | |
| Domain | MBD | 3.77e-03 | 11 | 159 | 2 | SM00391 | |
| Domain | MBD | 3.77e-03 | 11 | 159 | 2 | PS50982 | |
| Domain | Methyl_CpG_DNA-bd | 3.77e-03 | 11 | 159 | 2 | IPR001739 | |
| Domain | MBD | 3.77e-03 | 11 | 159 | 2 | PF01429 | |
| Domain | DNA-bd_dom | 3.77e-03 | 11 | 159 | 2 | IPR016177 | |
| Domain | EH | 3.77e-03 | 11 | 159 | 2 | PS50031 | |
| Domain | EH | 3.77e-03 | 11 | 159 | 2 | SM00027 | |
| Domain | EH_dom | 3.77e-03 | 11 | 159 | 2 | IPR000261 | |
| Domain | CH-domain | 3.85e-03 | 75 | 159 | 4 | IPR001715 | |
| Domain | MYB_LIKE | 4.11e-03 | 38 | 159 | 3 | PS50090 | |
| Domain | Snf7_fam | 4.49e-03 | 12 | 159 | 2 | IPR005024 | |
| Domain | Snf7 | 4.49e-03 | 12 | 159 | 2 | PF03357 | |
| Domain | SET | 5.09e-03 | 41 | 159 | 3 | PF00856 | |
| Domain | SET | 7.03e-03 | 46 | 159 | 3 | SM00317 | |
| Domain | EGF-like_CS | 7.10e-03 | 261 | 159 | 7 | IPR013032 | |
| Domain | - | 7.80e-03 | 333 | 159 | 8 | 2.130.10.10 | |
| Domain | Post-SET_dom | 7.99e-03 | 16 | 159 | 2 | IPR003616 | |
| Domain | PostSET | 7.99e-03 | 16 | 159 | 2 | SM00508 | |
| Domain | POST_SET | 7.99e-03 | 16 | 159 | 2 | PS50868 | |
| Domain | WD40/YVTN_repeat-like_dom | 8.07e-03 | 335 | 159 | 8 | IPR015943 | |
| Domain | EF_HAND_1 | 8.10e-03 | 204 | 159 | 6 | PS00018 | |
| Domain | WD40 | 8.16e-03 | 268 | 159 | 7 | SM00320 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | PRKD2 TRPM4 SYNRG SETD1B KMT2B ZDHHC5 MED14 CC2D1A SLC10A3 PIP5K1C WNK1 BIRC6 MXD4 PPP1R26 NHSL1 ZGPAT NCOR2 FZR1 ARHGEF40 DST SUGP2 SYNJ1 ZNF592 EHMT1 HERC1 C1orf50 PRRC2B | 1.84e-12 | 1105 | 162 | 27 | 35748872 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | TPR SYNRG SMARCA5 NANP USP28 GPATCH1 ECD CC2D1A CHMP4B WNK1 GTF2E1 DDX46 GTF2I DST SUGP2 SYNJ1 CTCF BAZ2A PES1 KIF5B PIH1D1 NIPBL PCM1 PRRC2B FTSJ3 | 1.88e-12 | 934 | 162 | 25 | 33916271 |
| Pubmed | TPR SMARCA5 KRI1 LCP1 BIRC6 DDX46 GTF2I DST SUGP2 CTCF BAZ2A PES1 RPF2 UTP20 KIF5B LAS1L NIPBL ZMYM3 PCM1 PRRC2B FTSJ3 | 4.35e-12 | 653 | 162 | 21 | 22586326 | |
| Pubmed | CYC1 TRPM4 KMT2B CAMSAP3 MED14 GON4L CMSS1 POLR1G CHMP4B ZGPAT ZC3H7A RFTN1 GTF2F1 DDX46 DST STX18 CTCF ZNF592 BAZ2A PLEKHG3 PES1 RPF2 EHMT1 UTP20 LAS1L NIPBL PBXIP1 ZMYM3 | 3.39e-10 | 1497 | 162 | 28 | 31527615 | |
| Pubmed | The functional interactome of PYHIN immune regulators reveals IFIX is a sensor of viral DNA. | SMARCA5 KRI1 LAMB1 CHMP4B GTF2I SUGP2 CTCF BAZ2A PES1 RPF2 UTP20 KIF5B LAS1L FTSJ3 | 1.17e-09 | 349 | 162 | 14 | 25665578 |
| Pubmed | TPR SMARCA5 RPS6KB1 CAMSAP3 CC2D1A POLR1G WNK1 ZNF8 DFFA GTF2F1 GTF2I MTCL1 LAS1L NIPBL PCM1 FTSJ3 | 2.09e-09 | 503 | 162 | 16 | 16964243 | |
| Pubmed | TPR SMARCA5 USP28 MED14 NSMCE3 POLR1G EHD2 DFFA NCOR2 GTF2E1 GTF2F1 DDX46 GTF2I SUGP2 SBNO1 CTCF ZNF592 PES1 EHMT1 CDKN2AIPNL NIPBL CDCA7L | 2.28e-09 | 1014 | 162 | 22 | 32416067 | |
| Pubmed | SMARCA5 KMT2B KRI1 GON4L CC2D1A ACTL6A CHMP4B NCOR2 FBN1 GTF2I DST SUGP2 CTCF ZNF592 GLI2 PES1 MITF EHMT1 HERC1 LAS1L NIPBL ZMYM3 PCM1 PRRC2B SORL1 FTSJ3 | 2.79e-09 | 1429 | 162 | 26 | 35140242 | |
| Pubmed | TPR SMARCA5 KMT2B KRI1 ACTL6A POLR1G DDX46 GTF2I SUGP2 CTCF ZNF592 PES1 RPF2 EHMT1 UTP20 C4A LAS1L CDCA7L ZMYM3 FTSJ3 | 3.15e-09 | 847 | 162 | 20 | 35850772 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | SYNRG CPNE8 RPS6KB1 GPATCH1 ECD PKD1L1 CAMSAP3 KRI1 CC2D1A KBTBD2 LCP1 ZC3H7A HROB SYNJ1 SYNJ2 KIF5B PIH1D1 PCM1 PRRC2B FTSJ3 | 3.55e-09 | 853 | 162 | 20 | 28718761 |
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | SMARCA5 CENPT DCUN1D5 MED14 CC2D1A ACTL6A JMY GTF2I CTCF ZNF592 PES1 RPF2 LAS1L PLCH1 NIPBL FTSJ3 | 4.75e-09 | 533 | 162 | 16 | 30554943 |
| Pubmed | AMBN PRKD2 SMARCA5 LAMB1 ACTL6A POLR1G ZNF8 ARHGAP4 NCOR2 ARHGEF40 SUGP2 CTCF ZNF592 BAZ2A EHMT1 C1orf50 VAV1 ZMYM3 PCM1 PRRC2B SORL1 FTSJ3 | 1.28e-08 | 1116 | 162 | 22 | 31753913 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | TPR SMARCA5 SETD1B ACTL6A CMSS1 POLR1G BIRC6 ZGPAT ZC3H7A NCOR2 ARHGEF40 GTF2I DST SUGP2 BAZ2A PLEKHG3 PES1 RPF2 UTP20 KIF5B LAS1L NIPBL ZMYM3 FTSJ3 | 1.98e-08 | 1353 | 162 | 24 | 29467282 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | TPR SYNRG SMARCA5 KMT2B CAMSAP3 MED14 NSMCE3 POLR1G NCOR2 DDX46 GTF2I SUGP2 ZNF592 BAZ2A UTP20 NIPBL ZMYM3 PCM1 | 2.57e-08 | 774 | 162 | 18 | 15302935 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | SMARCA5 CENPT KMT2B DCUN1D5 BAZ2B ACTL6A ZNF8 GTF2E1 GTF2I SBNO1 ZNF592 BAZ2A PES1 EHMT1 NIPBL ZMYM3 | 2.98e-08 | 608 | 162 | 16 | 36089195 |
| Pubmed | TPR SYNRG SMARCA5 KMT2B MED14 CC2D1A ACTL6A DDX46 GTF2I SUGP2 SYNJ1 BAZ2A KIF5B PCM1 PRRC2B | 5.05e-08 | 549 | 162 | 15 | 38280479 | |
| Pubmed | Regulation of CHMP4/ESCRT-III function in human immunodeficiency virus type 1 budding by CC2D1A. | 9.92e-08 | 3 | 162 | 3 | 22258254 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | CYC1 TPR ECD LAMB1 ACTL6A NSMCE3 CHMP4B ZNF8 FZR1 GTF2F1 DDX46 GTF2I SYNJ2 CTCF EHMT1 MTCL1 GNAS NIPBL ZMYM3 PCM1 PRRC2B | 1.10e-07 | 1155 | 162 | 21 | 20360068 |
| Pubmed | 1.38e-07 | 125 | 162 | 8 | 29467281 | ||
| Pubmed | KSHV episome tethering sites on host chromosomes and regulation of latency-lytic switch by CHD4. | 1.87e-07 | 130 | 162 | 8 | 35545047 | |
| Pubmed | 3.84e-07 | 196 | 162 | 9 | 19334288 | ||
| Pubmed | CPNE8 SMARCA5 KRI1 CC2D1A CMSS1 CHMP4B ITGB1 ARHGEF40 DDX46 GTF2I SUGP2 CTCF PES1 COL14A1 C4B KIF5B GNAS LAS1L CDKN2AIPNL PCM1 PRRC2B FTSJ3 | 4.51e-07 | 1371 | 162 | 22 | 36244648 | |
| Pubmed | SMARCA5 KRI1 CMSS1 LCP1 POLR1G GTF2I SUGP2 CTCF PES1 RPF2 UTP20 LAS1L FTSJ3 | 4.83e-07 | 483 | 162 | 13 | 36912080 | |
| Pubmed | Oct4 links multiple epigenetic pathways to the pluripotency network. | 5.15e-07 | 203 | 162 | 9 | 22083510 | |
| Pubmed | ZMYM3 regulates BRCA1 localization at damaged chromatin to promote DNA repair. | 5.59e-07 | 150 | 162 | 8 | 28242625 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | CYC1 TPR SMARCA5 CENPT BAZ2B GPATCH1 KRI1 NSMCE3 NCOR2 DDX46 GTF2I SUGP2 CTCF BAZ2A LAS1L NIPBL PCM1 FTSJ3 | 5.62e-07 | 954 | 162 | 18 | 36373674 |
| Pubmed | 5.69e-07 | 103 | 162 | 7 | 10819331 | ||
| Pubmed | 6.07e-07 | 104 | 162 | 7 | 9205841 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | SYNRG CAMSAP3 CC2D1A WNK1 MAP3K6 NHSL1 DST SYNJ1 SYNJ2 PLEKHG3 TESK2 KIF5B MTCL1 GNAS PLCH1 WNK4 PCM1 | 6.36e-07 | 861 | 162 | 17 | 36931259 |
| Pubmed | 6.84e-07 | 210 | 162 | 9 | 16565220 | ||
| Pubmed | TPR KMT2B CAMSAP3 BIRC6 ZNF8 NCOR2 GTF2I DST SYNJ1 ZNF592 ZMYM3 PCM1 | 6.90e-07 | 418 | 162 | 12 | 34709266 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | SMARCA5 KMT2B BAZ2B GPATCH1 ACTL6A POLR1G MXD4 NCOR2 DDX46 GTF2I DST CTCF BAZ2A MITF EHMT1 UTP20 LAS1L NIPBL CDCA7L ZMYM3 FTSJ3 | 7.05e-07 | 1294 | 162 | 21 | 30804502 |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | SYNRG KRT14 SETD1B USP28 WNK1 ZC3H7A NCOR2 GTF2F1 SYNJ1 GNAS ZMYM3 PCM1 PRRC2B SORL1 | 7.47e-07 | 588 | 162 | 14 | 38580884 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | CYC1 TPR SMARCA5 KRT14 ECD KRI1 CC2D1A CMSS1 WNK1 ITGB1 BIRC6 ZGPAT GTF2E1 GTF2F1 DDX46 GTF2I SBNO1 KIF5B MTCL1 PIH1D1 NIPBL FTSJ3 | 7.63e-07 | 1415 | 162 | 22 | 28515276 |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | SMARCA5 USP28 KRI1 CMSS1 POLR1G PTGS2 RFTN1 NCOR2 GTF2I SUGP2 CTCF ZNF592 PES1 RPF2 UTP20 LAS1L CDKN2AIPNL FTSJ3 | 9.40e-07 | 989 | 162 | 18 | 36424410 |
| Pubmed | 9.85e-07 | 5 | 162 | 3 | 10662543 | ||
| Pubmed | CPNE8 ECD KRI1 LAMB1 ACTL6A CHMP4B ITGB1 PTGFRN JMY EHD2 DDX46 GTF2I DST STX18 PLEKHG3 PES1 RPF2 GNAS LAS1L PBXIP1 PCM1 PRRC2B | 1.02e-06 | 1440 | 162 | 22 | 30833792 | |
| Pubmed | KMT2B BAZ2B MED14 CC2D1A ACTL6A CMSS1 LCP1 CHMP4B NCOR2 GTF2F1 GTF2I SUGP2 PES1 EHMT1 KIF5B NIPBL ZMYM3 PCM1 PRRC2B | 1.04e-06 | 1103 | 162 | 19 | 34189442 | |
| Pubmed | 1.13e-06 | 72 | 162 | 6 | 31248990 | ||
| Pubmed | 1.44e-06 | 75 | 162 | 6 | 29459360 | ||
| Pubmed | 1.51e-06 | 119 | 162 | 7 | 23508102 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | TPR CPNE8 SMARCA5 KRT14 ITGB1 DDX46 DST SUGP2 PLEKHG3 PES1 RPF2 UTP20 KIF5B GNAS LAS1L NIPBL PCM1 FTSJ3 | 1.54e-06 | 1024 | 162 | 18 | 24711643 |
| Pubmed | 1.68e-06 | 234 | 162 | 9 | 36243803 | ||
| Pubmed | CPNE8 ECD ZDHHC5 KRI1 LAMB1 CC2D1A ITGB1 DMXL1 ZC3H7A STX18 BAZ2A PES1 RPF2 EHMT1 COL14A1 GNAS LAS1L PLCH1 PIH1D1 PBXIP1 PCM1 FTSJ3 | 1.72e-06 | 1487 | 162 | 22 | 33957083 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | TPR AAMP CPNE8 SMARCA5 KRT14 ECD KRI1 ACTL6A CMSS1 FZR1 GTF2I DST PLEKHG3 PES1 RPF2 UTP20 KIF5B GNAS LAS1L FTSJ3 | 1.79e-06 | 1257 | 162 | 20 | 36526897 |
| Pubmed | Androgen-dependent hereditary mouse keratoconus: linkage to an MHC region. | 1.96e-06 | 6 | 162 | 3 | 11773012 | |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | USP28 ZDHHC5 CMSS1 ITGB1 ZC3H7A FBN1 SUGP2 SBNO1 UTP20 MTX1 C1orf50 PBXIP1 PCM1 PRRC2B FTSJ3 | 2.74e-06 | 754 | 162 | 15 | 33060197 |
| Pubmed | Recombination in the class III region of the mouse major histocompatibility complex. | 3.11e-06 | 22 | 162 | 4 | 7916002 | |
| Pubmed | 3.11e-06 | 22 | 162 | 4 | 27527664 | ||
| Pubmed | TPR KRT14 ZNF142 LAMB1 WNK1 ZGPAT ZC3H7A DST SYNJ2 C4A KIF5B HERPUD1 | 3.28e-06 | 486 | 162 | 12 | 20936779 | |
| Pubmed | Elucidation of the BMI1 interactome identifies novel regulatory roles in glioblastoma. | 3.64e-06 | 329 | 162 | 10 | 34316702 | |
| Pubmed | ZBTB2 protein is a new partner of the Nucleosome Remodeling and Deacetylase (NuRD) complex. | 3.74e-06 | 330 | 162 | 10 | 33301849 | |
| Pubmed | PRUNE2 BAZ2B ZDHHC5 ATG14 WNK1 BIRC6 PTGFRN PPP1R26 RFTN1 PLEKHG3 PLCH1 HERPUD1 | 3.80e-06 | 493 | 162 | 12 | 15368895 | |
| Pubmed | KRT14 GPATCH1 ZDHHC5 CC2D1A KBTBD2 ITGB1 BIRC6 DMXL1 GTF2I DST SUGP2 EHMT1 PIH1D1 PCM1 PRRC2B | 3.94e-06 | 777 | 162 | 15 | 35844135 | |
| Pubmed | Transcription factor protein interactomes reveal genetic determinants in heart disease. | SMARCA5 BAZ2B ACTL6A CHMP4B NCOR2 GTF2F1 GTF2I CHMP4A SUGP2 BAZ2A ZMYM3 | 3.98e-06 | 411 | 162 | 11 | 35182466 |
| Pubmed | PRUNE2 KRT14 LAMB1 CMSS1 POLR1G DNAH1 DCAF8L1 FER1L4 PES1 RPF2 CDKN2AIPNL FTSJ3 | 4.04e-06 | 496 | 162 | 12 | 31343991 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | CYC1 SMARCA5 CAMSAP3 ACTL6A LCP1 DDX46 ZNF592 SCN9A C4A C4B HERC1 WNK4 | 4.12e-06 | 497 | 162 | 12 | 36774506 |
| Pubmed | TPR SMARCA5 NSMCE3 GTF2F1 GTF2I PES1 RPF2 UTP20 LAS1L NIPBL FTSJ3 | 4.78e-06 | 419 | 162 | 11 | 15635413 | |
| Pubmed | A secretory kinase complex regulates extracellular protein phosphorylation. | 5.46e-06 | 8 | 162 | 3 | 25789606 | |
| Pubmed | Molecular genetics of the human MHC complement gene cluster. | 5.46e-06 | 8 | 162 | 3 | 10072631 | |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 7.86e-06 | 283 | 162 | 9 | 30585729 | |
| Pubmed | 9.15e-06 | 60 | 162 | 5 | 34761192 | ||
| Pubmed | 9.48e-06 | 157 | 162 | 7 | 30186101 | ||
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | TPR PRKD2 SMARCA5 CMSS1 POLR1G CHMP4B DDX46 GTF2I DST PLEKHG3 PES1 UTP20 KIF5B GNAS LAS1L FTSJ3 | 1.02e-05 | 949 | 162 | 16 | 36574265 |
| Pubmed | CENPT ECD MED14 GON4L LCP1 CHMP4B WNK1 ZNF8 GTF2F1 DST ZNF592 KIF5B PCM1 | 1.13e-05 | 645 | 162 | 13 | 25281560 | |
| Pubmed | 1.16e-05 | 10 | 162 | 3 | 30429287 | ||
| Pubmed | TPR GPRASP1 NYAP2 USP28 RPS6KB1 CAMSAP3 NCOR2 DST SYNJ1 CTCF EHMT1 KIF5B MTCL1 NIPBL PCM1 PRRC2B | 1.22e-05 | 963 | 162 | 16 | 28671696 | |
| Pubmed | RPS6KB1 CAMSAP3 GON4L MAP3K6 GTF2F1 ARHGEF40 DST C4A C4B PLCH1 PBXIP1 PRRC2B SORL1 | 1.23e-05 | 650 | 162 | 13 | 38777146 | |
| Pubmed | 1.26e-05 | 64 | 162 | 5 | 22261194 | ||
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | TPR SMARCA5 DCUN1D5 USP28 ACTL6A CMSS1 ITGB1 MXD4 NCOR2 SUGP2 PES1 UTP20 KIF5B ZMYM3 SORL1 | 1.26e-05 | 857 | 162 | 15 | 25609649 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | CYC1 SMARCA5 KRT14 MED14 ACTL6A ZNF8 DDX46 NWD2 DST SUGP2 PES1 RPF2 EHMT1 NIPBL TNXB PBXIP1 ZMYM3 | 1.32e-05 | 1082 | 162 | 17 | 38697112 |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | CYC1 ZNF142 ZDHHC5 METAP1D ITGB1 PTGFRN AXIN1 NCOR2 STX18 CTCF GLI2 PES1 FAM20B GNAS MTX1 HERPUD1 PBXIP1 ZMYM3 | 1.40e-05 | 1203 | 162 | 18 | 29180619 |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | SETD1B CAMSAP3 PIP5K1C DMXL1 NCOR2 DDX46 NWD2 SYNJ1 SCN9A PCM1 PRRC2B | 1.54e-05 | 475 | 162 | 11 | 31040226 |
| Pubmed | Organizations and gene duplications of the human and mouse MHC complement gene clusters. | 1.59e-05 | 11 | 162 | 3 | 10686478 | |
| Pubmed | 1.92e-05 | 242 | 162 | 8 | 34011540 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 22737222 | ||
| Pubmed | Deficiency of C4 from donor or recipient mouse fails to prevent renal allograft rejection. | 2.16e-05 | 2 | 162 | 2 | 16565498 | |
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 15998580 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 19062096 | ||
| Pubmed | Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice. | 2.16e-05 | 2 | 162 | 2 | 19933335 | |
| Pubmed | Structural basis for the C4d.1/C4d.2 serologic allotypes of murine complement component C4. | 2.16e-05 | 2 | 162 | 2 | 2459207 | |
| Pubmed | Antigen-induced B cell apoptosis is independent of complement C4. | 2.16e-05 | 2 | 162 | 2 | 17645767 | |
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 12207352 | ||
| Pubmed | Complement C4A and C4B Gene Copy Number Study in Alzheimer's Disease Patients. | 2.16e-05 | 2 | 162 | 2 | 27758680 | |
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 22387014 | ||
| Pubmed | Complement C4 maintains peripheral B-cell tolerance in a myeloid cell dependent manner. | 2.16e-05 | 2 | 162 | 2 | 23749435 | |
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 23918728 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 21704025 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 27878645 | ||
| Pubmed | Molecular genetics of androgen-dependent and -independent expression of mouse sex-limited protein. | 2.16e-05 | 2 | 162 | 2 | 3037333 | |
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 11726230 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 4216347 | ||
| Pubmed | Sequence determination of the thiolester site of the fourth component of human complement. | 2.16e-05 | 2 | 162 | 2 | 6950384 | |
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 21801332 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 8660986 | ||
| Pubmed | Tissue-specific RNA processing for the complement C4 gene transcript in the H-2k mouse strain. | 2.16e-05 | 2 | 162 | 2 | 8428773 | |
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 24638111 | ||
| Pubmed | Transcriptional repression of C4 complement by hepatitis C virus proteins. | 2.16e-05 | 2 | 162 | 2 | 21345967 | |
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 27019336 | ||
| Pubmed | 2.16e-05 | 2 | 162 | 2 | 22294159 | ||
| Interaction | NUP43 interactions | CENPT SETD1B KMT2B BAZ2B GPATCH1 KRI1 GON4L NCOR2 FBN1 GTF2I DST CTCF ZNF592 BAZ2A EHMT1 UTP20 KIF5B LAS1L NIPBL ZMYM3 FTSJ3 | 2.30e-08 | 625 | 159 | 21 | int:NUP43 |
| Interaction | NAA40 interactions | TPR SYNRG SMARCA5 NANP USP28 GPATCH1 ECD CC2D1A CHMP4B WNK1 GTF2E1 DDX46 GTF2I DST SUGP2 SYNJ1 CTCF BAZ2A PES1 KIF5B PIH1D1 NIPBL PCM1 PRRC2B FTSJ3 | 1.98e-07 | 978 | 159 | 25 | int:NAA40 |
| Interaction | POLR1G interactions | KMT2B BAZ2B KRI1 POLR1G GTF2E1 GTF2F1 SBNO1 CTCF ZNF592 PES1 EHMT1 UTP20 LAS1L PIH1D1 NIPBL ZMYM3 FTSJ3 | 3.43e-07 | 489 | 159 | 17 | int:POLR1G |
| Interaction | TOP3B interactions | PRKD2 TRPM4 SYNRG SETD1B KMT2B ZDHHC5 MED14 CC2D1A SLC10A3 PIP5K1C WNK1 BIRC6 MXD4 PPP1R26 NHSL1 ZGPAT ZC3H7A NCOR2 FZR1 ARHGEF40 GTF2I DST SUGP2 SYNJ1 ZNF592 EHMT1 GNAS HERC1 C1orf50 PRRC2B | 1.29e-06 | 1470 | 159 | 30 | int:TOP3B |
| Interaction | CDK8 interactions | MED14 GTF2E1 GTF2F1 SUGP2 SBNO1 PES1 EHMT1 LAS1L NIPBL PBXIP1 FTSJ3 | 1.57e-06 | 222 | 159 | 11 | int:CDK8 |
| Interaction | SIRT7 interactions | TPR KRI1 LCP1 BIRC6 DDX46 GTF2I DST SUGP2 CTCF BAZ2A PES1 RPF2 UTP20 KIF5B LAS1L NIPBL ZMYM3 PCM1 PRRC2B FTSJ3 | 1.74e-06 | 744 | 159 | 20 | int:SIRT7 |
| Interaction | MEN1 interactions | SMARCA5 SETD1B KMT2B GPATCH1 MED14 KRI1 ACTL6A POLR1G DDX46 GTF2I SUGP2 SBNO1 CTCF ZNF592 BAZ2A PES1 RPF2 EHMT1 UTP20 C4A LAS1L CDCA7L ZMYM3 FTSJ3 | 1.82e-06 | 1029 | 159 | 24 | int:MEN1 |
| Interaction | CENPA interactions | SMARCA5 CENPT KMT2B KRI1 GTF2F1 GTF2I BAZ2A PES1 EHMT1 UTP20 LAS1L NIPBL ZMYM3 FTSJ3 | 1.83e-06 | 377 | 159 | 14 | int:CENPA |
| Interaction | H2BC8 interactions | SMARCA5 CENPT KMT2B GON4L ACTL6A CHMP4B ZNF8 GTF2F1 GTF2I SBNO1 CTCF ZNF592 BAZ2A EHMT1 LAS1L NIPBL ZMYM3 | 3.22e-06 | 576 | 159 | 17 | int:H2BC8 |
| Interaction | HDAC1 interactions | TPR MBTPS1 SMARCA5 KMT2B CAMSAP3 GON4L ACTL6A POLR1G BIRC6 ZNF8 ZGPAT NCOR2 FZR1 GTF2I DST SYNJ1 CTCF ZNF592 BAZ2A GLI2 EHMT1 ZMYM3 PCM1 FTSJ3 | 6.44e-06 | 1108 | 159 | 24 | int:HDAC1 |
| Interaction | RCOR1 interactions | TPR SMARCA5 KMT2B CAMSAP3 BIRC6 ZNF8 NCOR2 DDX46 GTF2I DST SYNJ1 ZNF592 EHMT1 ZMYM3 PCM1 | 8.99e-06 | 494 | 159 | 15 | int:RCOR1 |
| Interaction | ZNF330 interactions | SMARCA5 KMT2B KRI1 ZNF8 GTF2E1 GTF2F1 ZNF592 PES1 EHMT1 UTP20 LAS1L NIPBL ZMYM3 FTSJ3 | 1.25e-05 | 446 | 159 | 14 | int:ZNF330 |
| Interaction | ANKFY1 interactions | CPNE8 CAMSAP3 CC2D1A JMY ARHGAP4 CHMP4A DST SYNJ1 PLEKHG3 VAV1 | 1.86e-05 | 236 | 159 | 10 | int:ANKFY1 |
| Interaction | POLR1E interactions | BAZ2B KRI1 POLR1G GTF2E1 GTF2F1 CTCF ZNF592 EHMT1 UTP20 LAS1L PIH1D1 FTSJ3 | 2.26e-05 | 350 | 159 | 12 | int:POLR1E |
| Interaction | AIM2 interactions | 2.69e-05 | 110 | 159 | 7 | int:AIM2 | |
| Interaction | USP7 interactions | TPR GPRASP1 SMARCA5 BEND5 USP28 KRI1 GON4L SLC10A3 NSMCE3 POLR1G PTGS2 AXIN1 FZR1 FBN1 GTF2I DST GLI2 PES1 EHMT1 HERC1 LAS1L PLCH1 PIH1D1 HERPUD1 CHST3 | 3.61e-05 | 1313 | 159 | 25 | int:USP7 |
| Interaction | H3C3 interactions | SMARCA5 KMT2B DCUN1D5 BAZ2B ACTL6A ZNF8 GTF2E1 GTF2I SBNO1 BAZ2A PES1 EHMT1 NIPBL ZMYM3 | 3.94e-05 | 495 | 159 | 14 | int:H3C3 |
| Interaction | PIP5K1C interactions | 4.57e-05 | 50 | 159 | 5 | int:PIP5K1C | |
| Interaction | SNRNP40 interactions | CENPT KMT2B BAZ2B GPATCH1 ECD KRI1 GON4L ZGPAT NCOR2 FZR1 GTF2F1 SUGP2 CTCF BAZ2A LAS1L FTSJ3 | 4.57e-05 | 637 | 159 | 16 | int:SNRNP40 |
| Interaction | SOX2 interactions | SMARCA5 BAZ2B KRI1 ACTL6A CMSS1 LCP1 CHMP4B PRTFDC1 NCOR2 FZR1 ARHGEF40 GTF2I CHMP4A SUGP2 CTCF PLEKHG3 PES1 MITF EHMT1 C4A LAS1L PLCH1 C1orf50 NIPBL PRRC2B FTSJ3 | 4.89e-05 | 1422 | 159 | 26 | int:SOX2 |
| Interaction | DOT1L interactions | TPR PRKD2 SMARCA5 KRI1 ACTL6A POLR1G DDX46 GTF2I CTCF ZNF592 PES1 RPF2 UTP20 C4A LAS1L CDCA7L ZMYM3 FTSJ3 | 7.04e-05 | 807 | 159 | 18 | int:DOT1L |
| Interaction | OBSL1 interactions | PRUNE2 TPR SMARCA5 KRT14 LAMB1 CMSS1 POLR1G DNAH1 DDX46 DST SUGP2 PES1 RPF2 UTP20 LAS1L CDKN2AIPNL NIPBL PCM1 FTSJ3 | 9.35e-05 | 902 | 159 | 19 | int:OBSL1 |
| Interaction | FBXO22 interactions | CYC1 SMARCA5 CAMSAP3 ACTL6A LCP1 NCOR2 DDX46 ZNF592 SCN9A C4A C4B HERC1 PIH1D1 WNK4 | 9.99e-05 | 540 | 159 | 14 | int:FBXO22 |
| Interaction | DAXX interactions | SMARCA5 SETD1B KRI1 CMSS1 CHMP4B AXIN1 FZR1 CHMP4A KIF5B PBXIP1 CDCA7L | 1.17e-04 | 353 | 159 | 11 | int:DAXX |
| Interaction | KLF16 interactions | KMT2B KRI1 GON4L GTF2I CTCF PES1 EHMT1 LAS1L NIPBL ZMYM3 PRRC2B FTSJ3 | 1.45e-04 | 425 | 159 | 12 | int:KLF16 |
| Interaction | BICD2 interactions | TPR RPS6KB1 GPATCH1 PKD1L1 CC2D1A LCP1 ZC3H7A HROB SYNJ1 SYNJ2 PIH1D1 PCM1 | 1.48e-04 | 426 | 159 | 12 | int:BICD2 |
| GeneFamily | G-patch domain containing|Minor histocompatibility antigens | 3.02e-04 | 22 | 109 | 3 | 579 | |
| GeneFamily | General transcription factors|Xeroderma pigmentosum complementation groups|DNA helicases|ERCC excision repair associated | 4.45e-04 | 25 | 109 | 3 | 565 | |
| GeneFamily | Charged multivesicular body proteins|ESCRT-III | 7.42e-04 | 7 | 109 | 2 | 1118 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 1.11e-03 | 34 | 109 | 3 | 487 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 1.26e-03 | 9 | 109 | 2 | 1234 | |
| GeneFamily | Zinc fingers CXXC-type|Methyl-CpG binding domain containing | 1.91e-03 | 11 | 109 | 2 | 1025 | |
| GeneFamily | Charged multivesicular body proteins|ESCRT-III associated factors | 1.91e-03 | 11 | 109 | 2 | 482 | |
| GeneFamily | EF-hand domain containing | 2.12e-03 | 219 | 109 | 6 | 863 | |
| GeneFamily | Fibronectin type III domain containing | 2.84e-03 | 160 | 109 | 5 | 555 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 4.01e-03 | 53 | 109 | 3 | 532 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 4.81e-03 | 181 | 109 | 5 | 694 | |
| GeneFamily | WD repeat domain containing | 5.11e-03 | 262 | 109 | 6 | 362 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - wildtype_emap-6674_k-means-cluster#3_top-relative-expression-ranked_1000 | 6.24e-07 | 129 | 161 | 9 | gudmap_developingKidney_e14.5 whole kidney - wildtype_1000_k3 | |
| ToppCell | LA|World / Chamber and Cluster_Paper | 5.57e-07 | 193 | 162 | 8 | d4bf89437216baf489ea0239136dcedf3b6714af | |
| ToppCell | Tracheal-10x5prime-Stromal-Peri/Epineurial_-NAF_endoneurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.76e-07 | 198 | 162 | 8 | 7a0c4dbc8c99968d42af00a718f4fedc544599ec | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.80e-06 | 168 | 162 | 7 | 4b2d29a7843bf45922038c093ca7ec0600756adc | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.15e-06 | 171 | 162 | 7 | 5d31fc9b60329d4ae3c77e4ca679359d9314397d | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.81e-06 | 176 | 162 | 7 | 2e94bbe17c0bb65dc58b4ebc0cb829258bd7373b | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.81e-06 | 176 | 162 | 7 | f33ab41d121b59d871ad7d48ca021524a027d2ef | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.10e-06 | 184 | 162 | 7 | e061e85c4bb19f49f6451ddd7a9077d7378ee365 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l20-1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.28e-06 | 185 | 162 | 7 | d5f5866924648a3c14e2596218fd548a31777aa3 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.67e-06 | 187 | 162 | 7 | e93cad16a087d1443cbf4e1690dc1b35d7a84c41 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m-Mesenchymal-mesenchymal_stem_cell|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.29e-06 | 190 | 162 | 7 | d13fd234caa3fc69d8a59bc0060cdacdf716ee55 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.74e-06 | 192 | 162 | 7 | 321850b0f881420c2d57d3e825e365c82fa511ab | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.74e-06 | 192 | 162 | 7 | a2c31390da4962bda9a936470b0b68fa1f5d47d1 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.74e-06 | 192 | 162 | 7 | 8937a59f6bbe07f671bdabbd3707dc9c17a14cd9 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.74e-06 | 192 | 162 | 7 | 29bee88b45e23f16543ffc7cc361bc5da5d16a2b | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.74e-06 | 192 | 162 | 7 | 7b48df661f61ce494bf6f0b9a74b0422e29c24bf | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.74e-06 | 192 | 162 | 7 | eeab1cef7c36ae824381952c5b2c982368c379fd | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.74e-06 | 192 | 162 | 7 | e4a7f2673f801b008ca67291db2fb2b9fd2955b8 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.74e-06 | 192 | 162 | 7 | ac1477433704573f95111eee6263b93668d2845e | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.74e-06 | 192 | 162 | 7 | 32acd89617934016cd135d2cc797e8e79ae1b37f | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.74e-06 | 192 | 162 | 7 | cdc652dbfabe41b324fd85c1ed933d29fb73a49f | |
| ToppCell | facs-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.74e-06 | 192 | 162 | 7 | cf2765d8bc074f7f9ee864eae632a3b705175842 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.97e-06 | 193 | 162 | 7 | 0a665531d581d4e3941e29d3f95569da8f166447 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.97e-06 | 193 | 162 | 7 | d9c20a092b507c43fcf7ccb04073fecd27d1749c | |
| ToppCell | droplet-Tongue-nan-3m|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.97e-06 | 193 | 162 | 7 | cba070019db30604ebddb610eedf92e48221ac58 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.97e-06 | 193 | 162 | 7 | 24ce1f37cca655415410d2403a52d1ebb3332280 | |
| ToppCell | droplet-Tongue-nan-3m-Epithelial|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.97e-06 | 193 | 162 | 7 | 07ddb9525b686c31fa7df4286557d1e58f7ead52 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m-Mesenchymal-mesenchymal_stem_cell|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.97e-06 | 193 | 162 | 7 | 160691b671710be10220803d788c2c961c236af1 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-25|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.21e-06 | 194 | 162 | 7 | 7b6ec45adb7ece3c8a7b78c5782413b5825effe2 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.21e-06 | 194 | 162 | 7 | 2d0cff9dc538a14518741e2a96d9d78442c81a72 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.46e-06 | 195 | 162 | 7 | 3c3703f092b6fc1b7333426fb5e2823bfb74bb57 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.71e-06 | 196 | 162 | 7 | d4676a6b0d9e417795fc9a6bcb1762d3dd656ca9 | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.71e-06 | 196 | 162 | 7 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-25|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.71e-06 | 196 | 162 | 7 | ed6047b48b6a96baa6a90c7af784e7c34b32824d | |
| ToppCell | Tracheal-10x5prime-Stromal-Peri/Epineurial_|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.97e-06 | 197 | 162 | 7 | 2cb1f557ce1400398975de94638126b4522567f3 | |
| ToppCell | facs-Trachea-nan-3m-Mesenchymal-fibroblast|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.24e-06 | 198 | 162 | 7 | 0dc7d59a07428a7b7e8bdc81f0e2417dd4ce3cf2 | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 8.51e-06 | 199 | 162 | 7 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | ILEUM-non-inflamed-(8)_Fibroblasts|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 8.51e-06 | 199 | 162 | 7 | d9d7f36b4b5592b7855448730044c90997b55499 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_myocytic-stroma-muscle_stem_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 8.51e-06 | 199 | 162 | 7 | 6200618e029063486719479c41eaf31798bd13cf | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_myofibroblast|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.51e-06 | 199 | 162 | 7 | 21335475bbfbad8a6943b8076a6c1c67f3eec5d3 | |
| ToppCell | ILEUM-non-inflamed-(8)_Fibroblast|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 8.51e-06 | 199 | 162 | 7 | 6a0df9a2f30480043f9c1d7fbdede17eb0910cac | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.79e-06 | 200 | 162 | 7 | 8978867bf69c830b1e48cac2ad6b512dbe60f149 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.79e-06 | 200 | 162 | 7 | ad3fdcef895400f929f2ae12ff9bd85fd46adb3a | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.79e-06 | 200 | 162 | 7 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | MS-Multiple_Sclerosis-Lymphocyte-T/NK-ILC|Multiple_Sclerosis / Disease, condition lineage and cell class | 8.79e-06 | 200 | 162 | 7 | ab9bdc9365cbdffe4ed246ce0c8a008a390e387e | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.79e-06 | 200 | 162 | 7 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.79e-06 | 200 | 162 | 7 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | Sepsis-Int-URO-Myeloid-tDC|Int-URO / Disease, condition lineage and cell class | 8.79e-06 | 200 | 162 | 7 | f5d0497a72da21cad24e0ef51c3dc4d024dbf294 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.79e-06 | 200 | 162 | 7 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | 343B-Epithelial_cells-Epithelial-E_(AT2)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.53e-05 | 145 | 162 | 6 | 80684ec249fa445c1b35f94608a4a6824d53f2d9 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-E_(AT2)|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.53e-05 | 145 | 162 | 6 | cb534333fba44b241b14fb0d7b74e843f4e7f9f8 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c2-CCL3L1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.96e-05 | 163 | 162 | 6 | 130c84bca3f72ab7d1a4fee2990c3d01600318ed | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.62e-05 | 169 | 162 | 6 | bb43abad2c049b7f4d307737347290e01b3339a3 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.62e-05 | 169 | 162 | 6 | 5f18e3f40a5b1b167903f37516ec8181e889c7c5 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.62e-05 | 169 | 162 | 6 | 8bfa2d3bb541d02f55d7c95b8fd156c8403befca | |
| ToppCell | 10x5'-blood-Myeloid_Dendritic-pDC|blood / Manually curated celltypes from each tissue | 3.74e-05 | 170 | 162 | 6 | 59cb1262ff319349d42b11afbec2a9035b7b79f2 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.13e-05 | 173 | 162 | 6 | 30d67738633493d47f06ae452424382f069b6c0a | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.26e-05 | 174 | 162 | 6 | a9c6edf5c3fc119c24425f921c5566a8356c30fe | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.40e-05 | 175 | 162 | 6 | 795a6564d5a75ffd35d39f5274b9e8d28708bbc8 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Degenerative_Distal_Convoluted_Tubule_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.69e-05 | 177 | 162 | 6 | dc846d0feb94d4c289553cc3ac9dac81d10409cb | |
| ToppCell | (05)_Ciliated-(4)_1wkpi|(05)_Ciliated / shred by cell type and Timepoint | 5.15e-05 | 180 | 162 | 6 | 85fc9b164147b28545e2397d32302eea03ef6346 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l25|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.15e-05 | 180 | 162 | 6 | c4068fe47408cfd899131a85fa4b7e5908926f94 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.15e-05 | 180 | 162 | 6 | 39ae8586efd91536e9ac6408d26de7e6d6237c41 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.31e-05 | 181 | 162 | 6 | 3462aa1c08fbaf613b6278ab2c7a5a0940bf537d | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.31e-05 | 181 | 162 | 6 | c26d3cbbc592299786d79d1b15fc6bead2aafb9a | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.31e-05 | 181 | 162 | 6 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.31e-05 | 181 | 162 | 6 | 6730e249cac55ae892cc567d9211615882f3dab4 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.47e-05 | 182 | 162 | 6 | 3dfa9187e9d2bab1d199079d29209c4648220ada | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.47e-05 | 182 | 162 | 6 | d179b5deb07c20d49eb6c58d5a65904f8921de3a | |
| ToppCell | facs-Lung-EPCAM-24m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.64e-05 | 183 | 162 | 6 | 63294d66e3ccf152ffe5d1237106764c14390b62 | |
| ToppCell | facs-Lung-EPCAM-24m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.64e-05 | 183 | 162 | 6 | 7e5c467fd1b156b928f1611a12ab4affb9f714b7 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.81e-05 | 184 | 162 | 6 | 4a9f798c67b9998bffe44242b210cc1e224ff5b1 | |
| ToppCell | droplet-Kidney-nan-21m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.81e-05 | 184 | 162 | 6 | 3bffadb0cb2e0d825bdb6cfc5d23f5436cbc3efd | |
| ToppCell | droplet-Kidney-nan-21m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.99e-05 | 185 | 162 | 6 | 33cc0e9d8b54cb7408b51235f2a70e044ebae04d | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.99e-05 | 185 | 162 | 6 | f98af3146ec2f44c30d31a662fb9c4fa3ca4f706 | |
| ToppCell | droplet-Fat-Scat-21m-Mesenchymal-Cd34+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.99e-05 | 185 | 162 | 6 | 01bbe1e09f9ccae837a03ea2cdd168fa10800942 | |
| ToppCell | droplet-Kidney-nan-21m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.99e-05 | 185 | 162 | 6 | 9954fc85b183c1cc45c3c24e3dadc7984ee6f649 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-24m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.17e-05 | 186 | 162 | 6 | ff6ccfdf2509f96caa10281c29a95b432f6c6dcc | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.17e-05 | 186 | 162 | 6 | 5473283fb95cee556b1f6934cf72169b676b5bcc | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 6.17e-05 | 186 | 162 | 6 | 9d3efe2a4feea2bc205a7e45b9b9f9ed9b3609ce | |
| ToppCell | droplet-Lung-21m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.17e-05 | 186 | 162 | 6 | 7c1807fca590cdccf7f5734460bac228d33964ca | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 6.17e-05 | 186 | 162 | 6 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Papillary|TCGA-Stomach / Sample_Type by Project: Shred V9 | 6.34e-05 | 115 | 162 | 5 | f02675a5ee12cb35535f82433d7f3f3e8349a677 | |
| ToppCell | facs-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l25-31|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.36e-05 | 187 | 162 | 6 | fa8f221b4c2df61eadaa9c77e4cf45848b00330b | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.36e-05 | 187 | 162 | 6 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | facs-Trachea-nan-24m-Mesenchymal|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.36e-05 | 187 | 162 | 6 | 71385068e3fd0bfa7822ae176113a49460c8636b | |
| ToppCell | ILEUM-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 6.36e-05 | 187 | 162 | 6 | 0099def970fbc828756fbf853eca2ce77b8cd342 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l20-25|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.36e-05 | 187 | 162 | 6 | 0d4b7da81036c2aa678654b9fe49c939d08fcd9b | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-basal_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.36e-05 | 187 | 162 | 6 | 9c1013720c248ef201d010806b6e7ad24205e8ee | |
| ToppCell | facs-Trachea-nan-24m-Mesenchymal-fibroblast|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.36e-05 | 187 | 162 | 6 | b930d5f7d410ac1f340babec5c937388f64cafc0 | |
| ToppCell | droplet-Bladder-Unstain-18m-Epithelial-bladder_mesenchymal_cell_(Scara5+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.36e-05 | 187 | 162 | 6 | 7beba2a5d5978f2ae7d8bde10815705cf2572211 | |
| ToppCell | facs-Trachea-nan-24m-Mesenchymal-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.36e-05 | 187 | 162 | 6 | e891e571f6bb9433a0046215de6cabd89ed1effc | |
| ToppCell | facs-Bladder-nan-24m-Epithelial-bladder_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.36e-05 | 187 | 162 | 6 | 2c145e9d11424939dd99012a8cedf5d998b966e9 | |
| ToppCell | droplet-Fat-Scat-21m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.55e-05 | 188 | 162 | 6 | e54e09d34e263d5709c337914809e61e74e20591 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.55e-05 | 188 | 162 | 6 | b382d18fb09fb2869f3c151efa71540a7f5ed229 | |
| ToppCell | droplet-Fat-Scat-21m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.55e-05 | 188 | 162 | 6 | 7fc9810ab14354cb512e2b1285562009c10203f5 | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.55e-05 | 188 | 162 | 6 | 2cfa41c64eccb28b5e22f0f91bbc921b75713245 | |
| ToppCell | (2)_Fibroblasts-(20)_Fibro-1|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 6.55e-05 | 188 | 162 | 6 | 409a7b69d02e87084ca955e3fe6c77230dee8861 | |
| ToppCell | facs-BAT-Fat-3m|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.74e-05 | 189 | 162 | 6 | 7ce71f9c81512ed38c804f025908746b4af3aab1 | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.74e-05 | 189 | 162 | 6 | 0a8b827bba1efd885ad6c06929251c741dc3a541 | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.74e-05 | 189 | 162 | 6 | 56f43e00d81cf3cdf0c39f8d7120f5beab72e258 | |
| Drug | (-)-Cinchonidine [485-71-2]; Down 200; 13.6uM; HL60; HG-U133A | 1.31e-06 | 197 | 159 | 10 | 1780_DN | |
| Drug | Sulconazole nitrate [61318-91-0]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 7.87e-06 | 190 | 159 | 9 | 3373_DN | |
| Drug | Melatonin [73-31-4]; Down 200; 17.2uM; MCF7; HT_HG-U133A | 8.93e-06 | 193 | 159 | 9 | 3293_DN | |
| Drug | Debrisoquin sulfate [581-88-4]; Up 200; 9uM; MCF7; HT_HG-U133A | 1.01e-05 | 196 | 159 | 9 | 5288_UP | |
| Drug | Lobelanidine hydrochloride [6112-86-3]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 1.05e-05 | 197 | 159 | 9 | 5500_DN | |
| Drug | Benzylpenicillin sodium [69-57-8]; Down 200; 11.2uM; PC3; HT_HG-U133A | 1.05e-05 | 197 | 159 | 9 | 4501_DN | |
| Drug | Meropenem [96036-03-2]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 1.05e-05 | 197 | 159 | 9 | 7180_UP | |
| Drug | 5211181; Down 200; 12uM; MCF7; HT_HG-U133A_EA | 1.10e-05 | 198 | 159 | 9 | 950_DN | |
| Drug | Metformin hydrochloride [1115-70-4]; Down 200; 24.2uM; MCF7; HT_HG-U133A | 1.10e-05 | 198 | 159 | 9 | 5487_DN | |
| Drug | Procainamide hydrochloride [614-39-1]; Down 200; 14.8uM; MCF7; HT_HG-U133A | 1.14e-05 | 199 | 159 | 9 | 2618_DN | |
| Drug | AC1OAGFB | PRKD2 TRPM4 ACTL6A PIP5K1C PTGS2 TG ARHGAP4 SYNJ1 SYNJ2 SCN9A GNAS HERC1 PLCH1 VAV1 | 2.67e-05 | 539 | 159 | 14 | CID006857345 |
| Drug | KME-4 | 2.72e-05 | 9 | 159 | 3 | CID006438990 | |
| Drug | ANFT | 3.87e-05 | 10 | 159 | 3 | CID000038052 | |
| Drug | 0179445-0000 [211246-22-9]; Down 200; 10uM; MCF7; HT_HG-U133A | 4.34e-05 | 182 | 159 | 8 | 3630_DN | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A | 5.66e-05 | 189 | 159 | 8 | 1651_DN | |
| Drug | Etofenamate [30544-47-9]; Up 200; 10.8uM; PC3; HT_HG-U133A | 6.56e-05 | 193 | 159 | 8 | 3989_UP | |
| Drug | Medrysone [2668-66-8]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 6.80e-05 | 194 | 159 | 8 | 4727_DN | |
| Drug | Bendroflumethiazide [73-48-3]; Down 200; 9.4uM; PC3; HT_HG-U133A | 6.80e-05 | 194 | 159 | 8 | 3758_DN | |
| Drug | indoprofen | 7.02e-05 | 12 | 159 | 3 | CID000003718 | |
| Drug | Perhexiline maleate [6724-53-4]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 7.05e-05 | 195 | 159 | 8 | 7441_DN | |
| Drug | Diphenidol hydrochloride [3254-89-5]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 7.05e-05 | 195 | 159 | 8 | 7406_UP | |
| Drug | Methoxamine hydrochloride [61-16-5]; Down 200; 16.2uM; PC3; HT_HG-U133A | 7.31e-05 | 196 | 159 | 8 | 6627_DN | |
| Drug | 0198306-0000 [212631-61-3]; Up 200; 10uM; PC3; HT_HG-U133A | 7.31e-05 | 196 | 159 | 8 | 7102_UP | |
| Drug | Mianserine hydrochloride [21535-47-7]; Up 200; 13.2uM; MCF7; HT_HG-U133A | 7.31e-05 | 196 | 159 | 8 | 6260_UP | |
| Drug | Hydrastinine hydrochloride [4884-68-8]; Down 200; 16.4uM; PC3; HT_HG-U133A | 7.31e-05 | 196 | 159 | 8 | 2119_DN | |
| Drug | Yohimbine hydrochloride [65-19-0]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 7.31e-05 | 196 | 159 | 8 | 2755_DN | |
| Drug | benserazide hydrochloride; Down 200; 10uM; SKMEL5; HG-U133A | 7.31e-05 | 196 | 159 | 8 | 631_DN | |
| Drug | Sulfadimethoxine [122-11-2]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 7.31e-05 | 196 | 159 | 8 | 4724_UP | |
| Drug | Nifenazone [2139-47-1]; Down 200; 13uM; PC3; HT_HG-U133A | 7.31e-05 | 196 | 159 | 8 | 7314_DN | |
| Drug | Hydroflumethiazide [135-09-1]; Up 200; 12uM; PC3; HT_HG-U133A | 7.58e-05 | 197 | 159 | 8 | 7259_UP | |
| Drug | S(-)Eticlopride hydrochloride [97612-24-3]; Down 200; 10.6uM; HL60; HT_HG-U133A | 7.58e-05 | 197 | 159 | 8 | 3056_DN | |
| Drug | Thioperamide maleate [106243-16-7]; Down 200; 9.8uM; HL60; HT_HG-U133A | 7.58e-05 | 197 | 159 | 8 | 3055_DN | |
| Drug | troglitazone; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 7.58e-05 | 197 | 159 | 8 | 1012_DN | |
| Drug | Betahistine mesylate [54856-23-4]; Down 200; 17.2uM; PC3; HT_HG-U133A | 7.58e-05 | 197 | 159 | 8 | 6611_DN | |
| Drug | Terbutaline hemisulfate [23031-32-5]; Down 200; 7.2uM; MCF7; HT_HG-U133A | 7.58e-05 | 197 | 159 | 8 | 6240_DN | |
| Drug | Metformin hydrochloride [1115-70-4]; Down 200; 24.2uM; MCF7; HT_HG-U133A | 7.85e-05 | 198 | 159 | 8 | 1694_DN | |
| Drug | Riluzole hydrochloride; Down 200; 14.8uM; PC3; HT_HG-U133A | 7.85e-05 | 198 | 159 | 8 | 3666_DN | |
| Drug | (+,-)-Octopamine hydrochloride [770-05-8]; Down 200; 21uM; MCF7; HT_HG-U133A | 7.85e-05 | 198 | 159 | 8 | 5469_DN | |
| Drug | radicicol; Down 200; 0.1uM; PC3; HG-U133A | 8.13e-05 | 199 | 159 | 8 | 484_DN | |
| Drug | estradiol, USP; Down 200; 0.01uM; PC3; HG-U133A | 8.42e-05 | 200 | 159 | 8 | 665_DN | |
| Drug | ICI 198,615 | 9.02e-05 | 34 | 159 | 4 | CID000115219 | |
| Drug | baicalin | 1.06e-04 | 67 | 159 | 5 | CID000064982 | |
| Drug | tiaprofenic acid | 1.15e-04 | 14 | 159 | 3 | CID000005468 | |
| Drug | tebufelone | 1.15e-04 | 14 | 159 | 3 | CID000060542 | |
| Disease | platelet component distribution width | PRUNE2 NYAP2 ATG14 LCP1 WNK1 JMY PRTFDC1 NCOR2 SYNJ2 BAZ2A PLEKHG3 TESK2 GNAS HERC1 TNXB VAV1 | 1.95e-06 | 755 | 152 | 16 | EFO_0007984 |
| Disease | Pseudohypoaldosteronism, Type I | 1.57e-05 | 10 | 152 | 3 | C0268436 | |
| Disease | Pseudohypoaldosteronism | 1.57e-05 | 10 | 152 | 3 | C0033805 | |
| Disease | Hyperpotassemia and Hypertension, Familial | 1.57e-05 | 10 | 152 | 3 | C2713447 | |
| Disease | Pseudohypoaldosteronism, Type I, Autosomal Recessive | 1.57e-05 | 10 | 152 | 3 | C1449843 | |
| Disease | Pseudohypoaldosteronism, Type II | 1.57e-05 | 10 | 152 | 3 | C1449844 | |
| Disease | Pseudohypoaldosteronism, Type I, Autosomal Dominant | 1.57e-05 | 10 | 152 | 3 | C1449842 | |
| Disease | sexual dimorphism measurement | B3GNT4 ZNF142 NYAP2 KMT2B LCP1 DCUN1D4 MXD4 ZGPAT NCOR2 HROB ARHGEF40 FBN1 ZNF592 GLI2 FER1L4 RAB11FIP4 HERC1 HERPUD1 | 1.68e-05 | 1106 | 152 | 18 | EFO_0021796 |
| Disease | EPIDERMOLYSIS BULLOSA SIMPLEX, AUTOSOMAL RECESSIVE (disorder) | 7.88e-05 | 3 | 152 | 2 | C1832926 | |
| Disease | triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement | 1.00e-04 | 206 | 152 | 7 | EFO_0004612, EFO_0020947 | |
| Disease | Pseudohypoaldosteronism type 2A | 1.57e-04 | 4 | 152 | 2 | cv:C1840389 | |
| Disease | Neuropathy, Hereditary Sensory And Autonomic, Type IIA | 1.57e-04 | 4 | 152 | 2 | C2752089 | |
| Disease | Pseudohypoaldosteronism, type 2 | 1.57e-04 | 4 | 152 | 2 | cv:C1449844 | |
| Disease | Hereditary sensory and autonomic neuropathy type 2 | 1.57e-04 | 4 | 152 | 2 | cv:C5574675 | |
| Disease | Neuropathy, hereditary sensory and autonomic, type 2A | 1.57e-04 | 4 | 152 | 2 | cv:C2752089 | |
| Disease | NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IIA | 1.57e-04 | 4 | 152 | 2 | 201300 | |
| Disease | cholesteryl esters to total lipids in large HDL percentage | 2.47e-04 | 59 | 152 | 4 | EFO_0022248 | |
| Disease | Dysphagia | 2.51e-04 | 24 | 152 | 3 | HP_0002015 | |
| Disease | Pigmentation Disorders | 2.61e-04 | 5 | 152 | 2 | C0549567 | |
| Disease | Incontinentia Pigmenti Achromians | 2.61e-04 | 5 | 152 | 2 | C0022283 | |
| Disease | Epidermolysis Bullosa Simplex | 2.61e-04 | 5 | 152 | 2 | C0079298 | |
| Disease | Schamberg Disease | 2.61e-04 | 5 | 152 | 2 | C0036305 | |
| Disease | triglycerides to total lipids in large HDL percentage | 2.64e-04 | 60 | 152 | 4 | EFO_0022330 | |
| Disease | colorectal cancer | DPP10 GPATCH1 WNK1 C8orf34 FZR1 FBN1 SYNJ2 GNAS PLCH1 NOTCH4 CHST3 | 3.10e-04 | 604 | 152 | 11 | MONDO_0005575 |
| Disease | pseudohypoaldosteronism (implicated_via_orthology) | 3.90e-04 | 6 | 152 | 2 | DOID:4479 (implicated_via_orthology) | |
| Disease | early-onset Parkinson's disease (implicated_via_orthology) | 3.90e-04 | 6 | 152 | 2 | DOID:0060894 (implicated_via_orthology) | |
| Disease | Squamous cell carcinoma | 4.67e-04 | 124 | 152 | 5 | C0007137 | |
| Disease | body surface area | WNK1 DCUN1D4 MXD4 AXIN1 PRTFDC1 NCOR2 ARHGEF40 FBN1 GLI2 GNAS CALN1 | 5.24e-04 | 643 | 152 | 11 | EFO_0022196 |
| Disease | cancer antigen 15.3 measurement | 5.44e-04 | 7 | 152 | 2 | EFO_0010585 | |
| Disease | Precocious Puberty | 5.44e-04 | 7 | 152 | 2 | C0034013 | |
| Disease | Cryptogenic sexual precocity | 5.44e-04 | 7 | 152 | 2 | C0271527 | |
| Disease | epidermolysis bullosa simplex (is_implicated_in) | 5.44e-04 | 7 | 152 | 2 | DOID:4644 (is_implicated_in) | |
| Disease | Central Precocious Puberty | 5.44e-04 | 7 | 152 | 2 | C0342543 | |
| Disease | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 5.93e-04 | 276 | 152 | 7 | EFO_0004612, EFO_0020943 | |
| Disease | obsolete_red blood cell distribution width | CFAP251 NYAP2 SETD1B KMT2B BAZ2B KBTBD2 LCP1 FREM3 WNK1 BIRC6 AXIN1 PRTFDC1 ZGPAT FZR1 GTF2I ACSBG1 HERC1 | 5.99e-04 | 1347 | 152 | 17 | EFO_0005192 |
| Disease | phosphatidylcholine measurement | 7.01e-04 | 284 | 152 | 7 | EFO_0010226 | |
| Disease | Testotoxicosis | 7.23e-04 | 8 | 152 | 2 | C1504412 | |
| Disease | beta-defensin 119 measurement | 7.23e-04 | 8 | 152 | 2 | EFO_0801419 | |
| Disease | central serous retinopathy | 7.23e-04 | 8 | 152 | 2 | EFO_0009784 | |
| Disease | pseudohypoaldosteronism (is_implicated_in) | 7.23e-04 | 8 | 152 | 2 | DOID:4479 (is_implicated_in) | |
| Disease | drug dependence | 7.77e-04 | 35 | 152 | 3 | EFO_0003890 | |
| Disease | response to radiation, prostate carcinoma, erectile dysfunction | 9.16e-04 | 37 | 152 | 3 | EFO_0001663, EFO_0004234, GO_0009314 | |
| Disease | lung cancer (implicated_via_orthology) | 9.27e-04 | 9 | 152 | 2 | DOID:1324 (implicated_via_orthology) | |
| Disease | alcohol dependence (implicated_via_orthology) | 9.27e-04 | 9 | 152 | 2 | DOID:0050741 (implicated_via_orthology) | |
| Disease | triglyceride measurement, phospholipid measurement | 9.78e-04 | 146 | 152 | 5 | EFO_0004530, EFO_0004639 | |
| Disease | Graves' disease (is_implicated_in) | 1.07e-03 | 39 | 152 | 3 | DOID:12361 (is_implicated_in) | |
| Disease | degree of unsaturation measurement | 1.07e-03 | 39 | 152 | 3 | EFO_0022261 | |
| Disease | ubiquitin-conjugating enzyme E2 G2 measurement | 1.15e-03 | 10 | 152 | 2 | EFO_0022035 | |
| Disease | Malignant neoplasm of tongue | 1.15e-03 | 10 | 152 | 2 | C0153349 | |
| Disease | Tongue Neoplasms | 1.15e-03 | 10 | 152 | 2 | C0040411 | |
| Disease | Adrenal Gland Neoplasms | 1.41e-03 | 11 | 152 | 2 | C0001624 | |
| Disease | Adrenal Cancer | 1.41e-03 | 11 | 152 | 2 | C0750887 | |
| Disease | free cholesterol to total lipids in very small VLDL percentage | 1.42e-03 | 43 | 152 | 3 | EFO_0022290 | |
| Disease | Endometrioma | 1.51e-03 | 161 | 152 | 5 | C0269102 | |
| Disease | Endometriosis | 1.51e-03 | 161 | 152 | 5 | C0014175 | |
| Disease | cholesterol to total lipids in large VLDL percentage | 1.62e-03 | 45 | 152 | 3 | EFO_0022236 | |
| Disease | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | 1.67e-03 | 243 | 152 | 6 | EFO_0004612, EFO_0020944 | |
| Disease | squamous cell lung carcinoma | 1.68e-03 | 165 | 152 | 5 | EFO_0000708 | |
| Disease | integral membrane protein 2B measurement | 1.68e-03 | 12 | 152 | 2 | EFO_0802634 | |
| Disease | Endogenous depression | 1.73e-03 | 46 | 152 | 3 | C0011573 | |
| Disease | major depressive episode | 1.84e-03 | 47 | 152 | 3 | EFO_0007634 | |
| Disease | fatty acid measurement | 1.97e-03 | 436 | 152 | 8 | EFO_0005110 | |
| Disease | Hereditary Motor and Sensory-Neuropathy Type II | 1.98e-03 | 13 | 152 | 2 | C0270914 | |
| Disease | Medulloblastoma | 2.20e-03 | 50 | 152 | 3 | C0025149 | |
| Disease | triglycerides to total lipids in medium LDL percentage | 2.20e-03 | 50 | 152 | 3 | EFO_0022334 | |
| Disease | polyunsaturated fatty acids to total fatty acids percentage | 2.20e-03 | 50 | 152 | 3 | EFO_0022303 | |
| Disease | familial hyperlipidemia | 2.24e-03 | 106 | 152 | 4 | MONDO_0001336 | |
| Disease | cholesterol efflux capacity measurement | 2.30e-03 | 14 | 152 | 2 | EFO_0009132 | |
| Disease | diabetic neuropathy (implicated_via_orthology) | 2.30e-03 | 14 | 152 | 2 | DOID:9743 (implicated_via_orthology) | |
| Disease | Liver Cirrhosis, Experimental | PRUNE2 SYNRG LCP1 ITGB1 PTGS2 PRTFDC1 NCOR2 FBN1 CDKN2AIPNL PCK1 VAV1 | 2.31e-03 | 774 | 152 | 11 | C0023893 |
| Disease | polyunsaturated fatty acids to monounsaturated fatty acids ratio | 2.33e-03 | 51 | 152 | 3 | EFO_0022302 | |
| Disease | cholesterol to total lipids in small VLDL percentage | 2.33e-03 | 51 | 152 | 3 | EFO_0022242 | |
| Disease | complement C4 measurement | 2.46e-03 | 52 | 152 | 3 | EFO_0004984 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, phospholipid measurement | 2.48e-03 | 109 | 152 | 4 | EFO_0004639, EFO_0008317, EFO_0008596 | |
| Disease | free cholesterol measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement | 2.56e-03 | 110 | 152 | 4 | EFO_0008317, EFO_0008591, EFO_0008596 | |
| Disease | triglycerides to total lipids in very large VLDL percentage | 2.60e-03 | 53 | 152 | 3 | EFO_0022340 | |
| Disease | free cholesterol to total lipids in small LDL percentage | 2.60e-03 | 53 | 152 | 3 | EFO_0022286 | |
| Disease | cholesteryl esters to total lipids in very large VLDL percentage | 2.60e-03 | 53 | 152 | 3 | EFO_0022258 | |
| Disease | Down syndrome (implicated_via_orthology) | 2.65e-03 | 15 | 152 | 2 | DOID:14250 (implicated_via_orthology) | |
| Disease | high density lipoprotein cholesterol measurement, metabolic syndrome | 2.65e-03 | 15 | 152 | 2 | EFO_0000195, EFO_0004612 | |
| Disease | cancer (implicated_via_orthology) | 2.73e-03 | 268 | 152 | 6 | DOID:162 (implicated_via_orthology) | |
| Disease | lipoprotein A measurement | 2.73e-03 | 112 | 152 | 4 | EFO_0006925 | |
| Disease | cholesterol to total lipids in very large VLDL percentage | 2.74e-03 | 54 | 152 | 3 | EFO_0022244 | |
| Disease | cholesterol to total lipids in large HDL percentage | 2.89e-03 | 55 | 152 | 3 | EFO_0022234 | |
| Disease | free cholesterol to total lipids in very large HDL percentage | 2.89e-03 | 55 | 152 | 3 | EFO_0022288 | |
| Disease | immature platelet fraction | 2.91e-03 | 114 | 152 | 4 | EFO_0009187 | |
| Disease | endoplasmic reticulum resident protein 29 measurement | 3.02e-03 | 16 | 152 | 2 | EFO_0020346 | |
| Disease | triglycerides to total lipids in medium HDL percentage | 3.04e-03 | 56 | 152 | 3 | EFO_0022333 | |
| Disease | cholesterol to total lipids in large LDL percentage | 3.04e-03 | 56 | 152 | 3 | EFO_0022235 | |
| Disease | free cholesterol to total lipids in large HDL percentage | 3.04e-03 | 56 | 152 | 3 | EFO_0022279 | |
| Disease | cholesteryl esters to total lipids in medium HDL percentage | 3.04e-03 | 56 | 152 | 3 | EFO_0022251 | |
| Disease | cholesteryl esters to total lipids in large VLDL percentage | 3.04e-03 | 56 | 152 | 3 | EFO_0022250 | |
| Disease | triglyceride measurement, high density lipoprotein cholesterol measurement | 3.04e-03 | 274 | 152 | 6 | EFO_0004530, EFO_0004612 | |
| Disease | Hypertensive disease | 3.10e-03 | 190 | 152 | 5 | C0020538 | |
| Disease | free cholesterol to total lipids in medium VLDL percentage | 3.20e-03 | 57 | 152 | 3 | EFO_0022284 | |
| Disease | low density lipoprotein particle size measurement | 3.36e-03 | 58 | 152 | 3 | EFO_0008593 | |
| Disease | triglycerides to total lipids in small VLDL percentage | 3.36e-03 | 58 | 152 | 3 | EFO_0022338 | |
| Disease | free cholesterol in medium HDL measurement | 3.36e-03 | 58 | 152 | 3 | EFO_0022267 | |
| Disease | cholesterol in medium HDL measurement | 3.53e-03 | 59 | 152 | 3 | EFO_0021903 | |
| Disease | Malignant neoplasm of skin | 3.53e-03 | 59 | 152 | 3 | C0007114 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GENLFAITDEGMDVP | 86 | Q6UXB8 | |
| PEEVFVEASPGTEDM | 156 | Q7L4P6 | |
| TDDVVGPEGMEKFCE | 116 | Q92564 | |
| GPEGMEKFCEDIGVE | 121 | Q92564 | |
| GAVAMAVTLEDGAEP | 16 | Q9H172 | |
| GVAPEMGLADVVAAD | 1381 | Q5SNV9 | |
| ISRPMGFGDDVDEDE | 146 | Q9BY43 | |
| LEGAAEPEEEEAVGM | 701 | Q8TER5 | |
| MGDPDLLEVLAEEGE | 1 | Q75V66 | |
| LAPVAAEAMEEGTVG | 2421 | Q9NR09 | |
| EVMEGTVAPEAEAAV | 76 | P49711 | |
| AAAIIESPGGEMEEA | 341 | P0C0L5 | |
| EGVVGSMEGPDDSEV | 71 | Q13685 | |
| LEESMEFVDPGVAGE | 401 | Q6ZNE5 | |
| SSEEVAGGREDPMAY | 261 | Q9NP70 | |
| MPVGDFFEERDTPEG | 616 | Q9UIF9 | |
| FVEGMESGEGLEEIA | 1396 | Q9UIF8 | |
| EDADFDGKPMVLVAG | 51 | Q9NZN4 | |
| AMEDEFGFEIPDIDA | 121 | O14561 | |
| DFPTAIGMVVERDDG | 36 | O96019 | |
| PGTEEALMEEGDEFE | 446 | Q49A92 | |
| PEASDGEGEGDTEVM | 21 | Q9BQ75 | |
| MEVTGDAGVPESGEI | 1 | O00273 | |
| KPVGFGEEFDEDELM | 151 | Q9H444 | |
| EVEVQDGPNEDGEMF | 151 | P08574 | |
| DGQVDFDEFMTILGP | 131 | Q9BXU9 | |
| FGLDSDVDVVMGDPV | 411 | Q9P1Y5 | |
| DPSVDMEDSGLFEAA | 1301 | Q9Y485 | |
| TEGSIEGFLEAPKME | 736 | A6H8M9 | |
| GPEGMEKFCEDIGVE | 66 | Q9BTE7 | |
| EEDSGTGESVMAPVD | 581 | O95905 | |
| IMDEEPGGQLVTDKF | 566 | Q8N608 | |
| EAPREATGENGETEM | 6 | Q8TBY9 | |
| IPGEVEASEFEMILD | 131 | Q9ULI1 | |
| EEAPDYGRGVVIMDD | 6 | Q9NRG1 | |
| MGTPVLEAVGDGEFV | 176 | P35558 | |
| EGGVSEEMKGPVQED | 501 | Q14699 | |
| PGFFPEDEEEAMTLA | 131 | Q86YS3 | |
| DSPEGGFDAIMQVAV | 246 | P05556 | |
| PVGGESDSEEMFEKT | 771 | Q9Y4B5 | |
| QMEEEGEEFTEGEHP | 1056 | Q9Y4B5 | |
| MNAQGGPIVEEDDEI | 246 | Q15011 | |
| QPEGTGMIDEEFTVA | 576 | P33176 | |
| FPPVVEDEEMEASGV | 696 | Q9Y618 | |
| EQEVDIEGMEFGPGE | 156 | Q14582 | |
| EEGMAFTIEPIITEG | 276 | Q6UB28 | |
| FGGAPEMTEQEIDTL | 271 | Q8N9B5 | |
| DQMDVIGVGGIDFED | 351 | Q14703 | |
| DVAEAESTGEMPGEE | 746 | O60721 | |
| PMLGLGEEEEEEETG | 146 | Q5T442 | |
| GDVNVEMDAAPGVDL | 266 | P02533 | |
| EEHEESQGPVGMETE | 5301 | Q03001 | |
| GTGCEPEEAVMIGDD | 191 | Q9H0R4 | |
| GLVPEETEENIEGEM | 301 | Q2LD37 | |
| GRPEDLEFTDMGGNV | 1681 | A9Z1Z3 | |
| DIPSADAAEMEEGFS | 2836 | Q15751 | |
| TAPAEEAEGAGEMLE | 626 | O95382 | |
| MTVISEGEGEAVEPV | 1526 | Q5SYE7 | |
| PEDFMDEEDLSEFGI | 91 | Q9BRR8 | |
| EEDGRGEPAMESSQI | 191 | Q15154 | |
| DEEGVPAVVIDMSGL | 311 | P13796 | |
| LSIGDGSVMEFEFPE | 66 | P09131 | |
| GSVMEFEFPEDSEGI | 71 | P09131 | |
| EFMEGGPQEADRLDE | 111 | Q76G19 | |
| DFMLEDEASGIGPEV | 26 | P07585 | |
| MDFTAFGDDDEIPQE | 1216 | Q6KC79 | |
| DGTEEFELDGEMVAL | 606 | Q8IY47 | |
| PGDCVMVGDTLETDI | 181 | Q8TBE9 | |
| AEDMAGVFDIDLDQP | 21 | P23443 | |
| GEALINGDVPMEEAT | 316 | Q9BZL6 | |
| DAIFGETMVEVGAPF | 501 | P35354 | |
| APVDGFNEEVEGMVH | 281 | P07942 | |
| EEEDRMEVGPFSTGQ | 601 | Q9Y4W2 | |
| MLGLEEGDLEDDFDP | 376 | Q8N9T8 | |
| ELEEPGMELECGVSS | 166 | Q8N3J3 | |
| EAPQIDFDAIMDDGD | 1506 | P10070 | |
| EDLGPDFEDMEVVSG | 1971 | Q9UMN6 | |
| EPFQEEIVAAGAMGS | 2001 | Q9UMN6 | |
| SDDEEFVGFRDDVPM | 21 | Q96GN5 | |
| GDPEEEEPVYIEMVG | 236 | Q9P242 | |
| VEGEFEATLTVMGDD | 226 | O60244 | |
| MSPDGEAIVTGAGDE | 451 | Q9UM11 | |
| VGSFEVPEDFQERME | 136 | Q9P2D7 | |
| GEYTVVAMQDGDPTE | 486 | Q8N9C0 | |
| EDAELFPIDDVFVGM | 296 | Q9C0J1 | |
| SEPIFGKNEGELMVE | 506 | Q6ZN84 | |
| GIIVGPDDSAVDMDE | 2116 | P35555 | |
| AMFGEEASDPVTGQE | 516 | Q05707 | |
| TAQGDPEEEVIGTVM | 771 | Q05707 | |
| VRMEEEGEDGDPSSG | 416 | O15169 | |
| EMEATGAQGPSRVEE | 346 | Q96BT3 | |
| EEIEDGGLFIPMEEQ | 221 | Q3T8J9 | |
| GLMIPEDGANDEELE | 31 | Q6P1N0 | |
| EFMELGNEVPEEALD | 251 | Q96GR2 | |
| RFDGEDGDPEAEMES | 671 | P14616 | |
| SEDVELESMGEGLFG | 76 | A6NGE4 | |
| EGNEMEGEELDPLDA | 216 | Q7L014 | |
| EGNEGTEMEVPAEDS | 281 | P78347 | |
| EDLFGLVPFEEIMGS | 201 | Q5H9B9 | |
| ELIDELGGPENVAEM | 876 | A3KN83 | |
| LGEETPMAADEGSAE | 26 | Q9H9B1 | |
| PVMVEFGEEDGLDNR | 1556 | Q8TDX9 | |
| MEDAAAPGRTEGVLE | 1 | Q9BV19 | |
| VGPAEFDAMVELDGD | 471 | Q86YQ8 | |
| AAAIIESPGGEMEEA | 341 | P0C0L4 | |
| GQLYGCEEEEMPEVE | 96 | Q8TAE6 | |
| APGTRTLGMAEEDEE | 451 | Q13505 | |
| DTMQGAEEEEPIIGS | 601 | Q5JY77 | |
| FPEMATVEIVDPGDE | 1871 | P0C091 | |
| EGAALDPDDMAFDVS | 716 | Q9P2B2 | |
| EFEEVADDPIVMVAG | 386 | P29083 | |
| IYQEEEMPESGAGSE | 56 | P35269 | |
| GKGMVAEEIEEEPAA | 871 | O75691 | |
| DLGEDDEDAPMITGF | 2191 | Q92673 | |
| LSEDVGMDIPFEEGV | 2761 | Q8WUY3 | |
| EEDQAGFRIPMSLGE | 91 | Q9NWS0 | |
| PTDIFAIGFEEMVEL | 581 | O43426 | |
| SPADIFAVGFEEMVE | 576 | O15056 | |
| GLAPVGEQDDFADFM | 681 | Q9UMZ2 | |
| SSEEEEEMGGAAQEP | 576 | A1L390 | |
| GAGEPYDIIDSSDEM | 86 | Q1AE95 | |
| MELEVPDEAESAEAG | 1 | O60331 | |
| EETMPFELDGEGFGD | 221 | Q5JWF2 | |
| TEGMEPEEGVTVESQ | 296 | O15446 | |
| GEGEEAEAEPMNSDE | 1136 | Q15858 | |
| DLPGVSIADEGETGM | 406 | Q8IY81 | |
| GVEDFREVDPIFGTM | 176 | Q07837 | |
| REVDPIFGTMEDFEN | 181 | Q07837 | |
| VAEESMASAGPEDFE | 1196 | Q9UPS6 | |
| MASAGPEDFEQDGEE | 1201 | Q9UPS6 | |
| GAPAVDSLGMEEEVD | 1221 | Q9UPS6 | |
| LVADFDPMGEEETTD | 101 | Q5T8A7 | |
| DEDGVVMCSGPEEGE | 1521 | Q99466 | |
| AEMPAQEDDLEGVVE | 736 | P98171 | |
| PMLIFAGDDFDVTED | 141 | Q9H7B2 | |
| DEEGGSSEPEEMADL | 576 | Q6PIS1 | |
| EMADGIEVEDLPQFT | 91 | Q96HQ2 | |
| SPIPVMEGDDDIEVF | 81 | O75503 | |
| QGDQGIVEELMEDDP | 271 | Q8NHS4 | |
| LGVEPAMEAAGEEEE | 101 | Q7LGC8 | |
| PEAEADGEELDGSDM | 421 | Q96CK0 | |
| MQSESGIVPDFEVGE | 1 | O75030 | |
| GLSESETGPMEEVER | 216 | Q96AQ6 | |
| EVDEFPTDGEMSAQE | 296 | O00541 | |
| EGVTQGDYTPMEDSE | 1896 | P12270 | |
| GKGEDELSPEEIQMF | 221 | Q9P2W9 | |
| IMPFPTEEESVGDED | 126 | P15498 | |
| ETEPACADGDIMEGS | 206 | O75063 | |
| CQLEEGGEPFMVERE | 51 | Q96K75 | |
| AAEMAVEVAEPEEGS | 1191 | Q92610 | |
| QESPVDLMEGEAEFE | 861 | Q8IX01 | |
| AGEDCGEEVPTIEGM | 741 | P22105 | |
| EAIASLPGEETEDMD | 86 | Q9NS37 | |
| LPGEETEDMDFLSGL | 91 | Q9NS37 | |
| ESEVGSMVGEGFIEV | 1551 | Q5JSZ5 | |
| EVSPGEAIYDVIGEM | 941 | Q4G0T1 | |
| EGAMVEGDVELLPSD | 331 | Q96RU2 | |
| VEEDAEMRGDQGTPT | 161 | Q96MG7 | |
| MFGDRGEIIDPFVEV | 751 | Q4KWH8 | |
| PEAFLDDGDMVLGDE | 271 | Q8IWR0 | |
| TFMDPGIFPRAEEDE | 66 | Q9C0B5 | |
| IGVEEPSVGASMLFD | 556 | P17098 | |
| PGGEEMDVAEENRAI | 166 | Q8N831 | |
| VEATATEEGPGNMEI | 61 | P52746 | |
| MLSEDVSVEPEGDQG | 1191 | Q9H4A3 | |
| AGPADAEMEEIFDDA | 51 | O60264 | |
| AGASEEMEVEERPAG | 536 | Q96S53 | |
| VDEAGQELEGMRSEP | 901 | P01266 | |
| DLDGDSPEEIAAAMV | 706 | Q96J92 | |
| MVVGTEEAEDGSAGV | 151 | Q8N5A5 | |
| ELEFDMDSVINGEGP | 721 | Q8TD43 | |
| AGDLPVDMEFGEDLL | 21 | Q14202 |